Global Immuno-Oncology Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Immuno-Oncology Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Immuno-Oncology (I-O) is an innovative area of research that seeks to help the body"s own immune system fight cancer. The goal is to address the unmet need for long-term survival in patients with advanced cancers.

According to our (Global Info Research) latest study, the global Immuno-Oncology market size was valued at US$ 52170 million in 2023 and is forecast to a readjusted size of USD 133690 million by 2030 with a CAGR of 14.6% during review period.

The industry"s leading producers are Bristol-Myers Squibb, Merck & Co and Roche AG, with revenues of 27.89%, 22.10% and 20.85%, respectively, in 2019.

This report is a detailed and comprehensive analysis for global Immuno-Oncology market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.

Key Features:

Global Immuno-Oncology market size and forecasts, in consumption value ($ Million), 2019-2030

Global Immuno-Oncology market size and forecasts by region and country, in consumption value ($ Million), 2019-2030

Global Immuno-Oncology market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030

Global Immuno-Oncology market shares of main players, in revenue ($ Million), 2019-2024

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Immuno-Oncology

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Immuno-Oncology market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bristol-Myers Squibb, Merck & Co., Inc., Roche AG, AstraZeneca, Plc, Sanofi S.A., Dendreon Pharmaceuticals, Novartis, Gilead Sciences Inc., Merck KGaA, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market segmentation

Immuno-Oncology market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segmentation

Immuno-Oncology market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Immune Checkpoint Inhibitors
Cytokine-Based Immunotherapy
Cancer Vaccines
CAR-T Cell Therapy
Others

Market segment by Application
Hospitals
Drugstores
Others

Market segment by players, this report covers
Bristol-Myers Squibb
Merck & Co., Inc.
Roche AG
AstraZeneca, Plc
Sanofi S.A.
Dendreon Pharmaceuticals
Novartis
Gilead Sciences Inc.
Merck KGaA

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:

Chapter 1, to describe Immuno-Oncology product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top players of Immuno-Oncology, with revenue, gross margin, and global market share of Immuno-Oncology from 2019 to 2024.

Chapter 3, the Immuno-Oncology competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Immuno-Oncology market forecast, by regions, by Type and by Application, with consumption value, from 2024 to 2030.

Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.

Chapter 12, the key raw materials and key suppliers, and industry chain of Immuno-Oncology.

Chapter 13, to describe Immuno-Oncology research findings and conclusion.